Nasdaq

Biogen's Plegridy Approved In Europe For Intramuscular Injection On RR Multiple Sclerosis

(RTTNews) - Biogen Inc. (BIIB) said that the European Commission has approved a new intramuscular or IM injection route of administration for Plegridy or peginterferon beta-1a for the treatment of ...

Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis ...

GA Depot is a long-acting injection version of the approved Glatiramer Acetate (GA, commercially available as Copaxone ® /Glatopa ® ). PPMS is characterized by continued worsening neurologic function ...
Nasdaq

The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis

CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the European Commission (EC) has approved a new intramuscular (IM) injection route of administration ...
Nature

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment

Interferon-β (IFN-β) is one of the major drugs for multiple sclerosis (MS) treatment. The purpose of this study was to characterize the transcriptional effects induced by intramuscular IFN-β-1a ...
Healio

Multiple intra-articular steroid hip injections linked with increased risk of PJI after THA

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients who received multiple intra-articular steroid hip injections prior to total hip ...